3P Clinical significance of achieving no evidence of disease in HER2-positive metastatic breast cancer: A multicenter study by Turkish Oncology Group (TOG)

Key Points

• This research aims to explore the clinical significance of achieving no evidence of disease in HER2-positive metastatic breast cancer and identify predictive factors.
• Conducted a multicenter study across various oncology centers
• Analyzed clinical data of patients with HER2-positive metastatic breast cancer
• Evaluated the association between achieving no evidence of disease and treatment outcomes
• Found that achieving no evidence of disease is linked to improved disease control
• Identified key predictive factors influencing the likelihood of achieving no evidence of disease
• Highlights the potential role of no evidence of disease as a meaningful treatment goal